Drug class
Selective topical histamine H1 receptor antagonist; antiallergic agent
Mechanism of action
Antagonises peripheral H1 histamine receptors in ocular and nasal tissues, reducing histamine-mediated itching, redness, sneezing and rhinorrhoea.
General use cases
- Treatment of allergic conjunctivitis with ophthalmic formulations
- Symptomatic relief of allergic rhinitis with intranasal formulations in countries where levocabastine products remain authorised; route-specific products are not interchangeable
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
